The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Highlights in Cancer Research: January 2023

October 17, 2025
Highlights in Cancer Research: November 2022

The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.

3. Breast tumor microenvironment structures are associated with genomic features and clinical outcome

  • 1. Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity
  • 2. A noncoding single-nucleotide polymorphism at 8q24 drives IDH1-mutant glioma formation
  • 3. Breast tumor microenvironment structures are associated with genomic features and clinical outcome
  • 4. A covalent inhibitor of K-Ras(G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapy
  • 5. Chronic exposure to carbon black ultrafine particles reprograms macrophage metabolism and accelerates lung cancer
  • 6. Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer
  • 7. Deciphering the immunopeptidome in vivo reveals new tumour antigens
  • 8. Lung fibroblasts facilitate pre-metastatic niche formation by remodeling the local immune microenvironment
  • 9. RASA2 ablation in T cells boosts antigen sensitivity and long-term function
  • 10. Sensitisation of cancer cells to radiotherapy by serine and glycine starvation
Previous
Next

Danenberg, E. et al. Nature Genetics. 54: 660–669 (2022).
doi: 10.1038/s41588-022-01041-y.

Summary of the findings

The functions of the tumour microenvironment (TME) are orchestrated by precise spatial organisation of specialised cells, yet we know very little about the multicellular structures that form within the TME. We systematically mapped TME structures in situ using imaging mass cytometry and multi-tiered spatial analysis of 693 breast tumours linked to genomic and clinical data. We borrowed methods used in the analysis of social networks to discover recurrent spatially conserved orientations of immune and stromal cells (TME structures). We identified 10 recurrent TME structures that varied by vascular content, stromal quiescence versus activation, and leukocyte composition. These TME structures had distinct enrichment patterns among breast cancer subtypes, and some were associated with genomic profiles indicative of immune escape. Regulatory and dysfunctional T cells co-occurred in large ‘suppressed expansion’ structures. These structures were characterized by high cellular diversity, proliferating cells, and enrichment for BRCA1 and CASP8 mutations, and predicted poor outcome in ER-positive disease. The landscape of multicellular structures revealed here links conserved spatial organisation to local TME function and holds potential for better patient stratification. All data have been deposited in the public domain, and should serve as a resource for other studies of the multicellular organisation of breast cancer.

Using imaging mass cytometry and multi-tiered spatial analysis, the landscape of 10 recurrent multicellular structures in the brest tumour microenvironment (TME) was mapped. Correlation with genomic features of the tumours revealed an association of TME features with genomic cancer subtypes and somatic alterations. Correlation with clinical features suggests these TME features are a key determinant of clinical outcome.
Read more in Nature Genetics

 

3. Breast tumor microenvironment structures are associated with genomic features and clinical outcome

  • 1. Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity
  • 2. A noncoding single-nucleotide polymorphism at 8q24 drives IDH1-mutant glioma formation
  • 3. Breast tumor microenvironment structures are associated with genomic features and clinical outcome
  • 4. A covalent inhibitor of K-Ras(G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapy
  • 5. Chronic exposure to carbon black ultrafine particles reprograms macrophage metabolism and accelerates lung cancer
  • 6. Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer
  • 7. Deciphering the immunopeptidome in vivo reveals new tumour antigens
  • 8. Lung fibroblasts facilitate pre-metastatic niche formation by remodeling the local immune microenvironment
  • 9. RASA2 ablation in T cells boosts antigen sensitivity and long-term function
  • 10. Sensitisation of cancer cells to radiotherapy by serine and glycine starvation
Previous
Next
Tags: EACR Top Ten Cancer Research PublicationsHighlights in Cancer Research

Related Posts

“A community that actively supports growth, resilience, and global collaboration” – what EACR membership means to a researcher from a low-income country

“A community that actively supports growth, resilience, and global collaboration” – what EACR membership means to a researcher from a low-income country

July 13, 2026

We caught up with Mounia Benbelkacem, a PhD researcher at the Laboratory of Cellular and Molecular Biology, Faculty of Biological Sciences, University of Science and Technology...

“Reinforced my desire to build and develop computational and bioinformatics capacity”- Aniefiok John Udoakang’s Travel Fellowship

“Reinforced my desire to build and develop computational and bioinformatics capacity”- Aniefiok John Udoakang’s Travel Fellowship

July 8, 2026

Aniefiok John Udoakang is a postdoctoral researcher at University of Medical Sciences, Ondo City, Ondo State, Nigeria who received an EACR Travel Fellowship to visit and...

“It seemed like an excellent opportunity to strengthen my project and expand my network.” – Ana Rita Barbosa de Matos’s Travel Fellowship

“It seemed like an excellent opportunity to strengthen my project and expand my network.” – Ana Rita Barbosa de Matos’s Travel Fellowship

July 6, 2026

Ana Rita Barbosa de Matos is a postdoctoral researcher at i3S, Portugal who received an EACR Travel Fellowship to visit and work at VHIO, Spain between...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

Advertisement Advertisement Advertisement
ADVERTISEMENT

RECENT POSTS

“A community that actively supports growth, resilience, and global collaboration” – what EACR membership means to a researcher from a low-income country
Community

“A community that actively supports growth, resilience, and global collaboration” – what EACR membership means to a researcher from a low-income country

July 13, 2026
EACR Travel Grant recipients at Cancer Genomics, Multiomics and Computational Biology 2026
Community

EACR Travel Grant recipients at Cancer Genomics, Multiomics and Computational Biology 2026

July 13, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR